Proactiveinvestors recommends
Additional Information
Market: NYSE AMEX
Sector: Medical
EPIC: BONE
Bacterin International Holdings
investor.bacterin.com

BACTERIN INTERNATIONAL HOLDINGS, INC. ("the "Company" or "Bacterin") develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and promote bone and other tissue growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and cartilage regeneration in knee and other joint surgeries.

Full Bacterin International Holdings profile here
Pdf

Bacterin promotes Nick Navarro to national sales manager

7th Feb 2012, 2:53 pm by Brad Lemaire
Bacterin promotes Nick Navarro to national sales manager

Bacterin International Holdings (NYSE:BONE) said Tuesday that it has promoted Nick Navarro to national sales manager. 

The company, which has about 117 employees, develops bone graft material and antimicrobial coatings for medical applications.

Its products are used to enhance fusion in spine surgery, back pain relief with a facet joint stabilization, promotion of bone growth in foot and ankle surgery.

Navarro has eight years of sales and management experience in the orthopaedic industry. He holds a psychology degree from the University of Iowa and a minor in business.

Under this role, he will be responsible for managing Bacterin’s hybrid distribution force by supporting product sales for all Bacterin divisions. 

Before his promotion, Navarro served various roles at Bacterin starting as a direct representative, then advanced to regional sales manager where he relocated to headquarters to serve as vice president of devices.

During his career, he has worked for Johnson and Johnson, specializing in wound management, and at Wright Medical as a foot and ankle hardware specialist.

Bacterin's president and chief executive, Guy Cook, said: “We were very pleased to promote a strong team member such as Nick. He has brought relevant industry experience to Bacterin and has produced at each level inside the company. We look forward to adding his performance and industry expertise to our sales management team.”

Bacterin’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone repair and dermal growth. The company's medical division also develops antimicrobial coatings that inhibit contamination.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.